House Committees Demand F.D.A. Records on Alzheimer’s Drug Approval by BY PAM BELLUCK


The agency approved Biogen’s Aduhelm “despite concerns raised by experts,” committee leaders said in a letter.

Published: September 2, 2021 at 05:04PM

from NYT Health https://ift.tt/3gWhw6I